UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:RBM6-ARIH2 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: RBM6-ARIH2 | FusionPDB ID: 72965 | FusionGDB2.0 ID: 72965 | Hgene | Tgene | Gene symbol | RBM6 | ARIH2 | Gene ID | 10180 | 10425 |
Gene name | RNA binding motif protein 6 | ariadne RBR E3 ubiquitin protein ligase 2 | |
Synonyms | 3G2|DEF-3|DEF3|HLC-11|NY-LU-12|g16 | ARI2|TRIAD1 | |
Cytomap | 3p21.31 | 3p21.31 | |
Type of gene | protein-coding | protein-coding | |
Description | RNA-binding protein 6RNA-binding protein DEF-3lung cancer antigen NY-LU-12lung cancer protooncogene 11 | E3 ubiquitin-protein ligase ARIH2RING-type E3 ubiquitin transferase ARIH2all-trans retinoic acid inducible RING fingerariadne homolog 2protein ariadne-2 homolog | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | O95376 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000441115, ENST00000266022, ENST00000422955, ENST00000442092, ENST00000443081, ENST00000539992, ENST00000421682, | ENST00000356401, ENST00000449376, ENST00000490095, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 31 X 22 X 13=8866 | 17 X 18 X 8=2448 |
# samples | 31 | 21 | |
** MAII score | log2(31/8866*10)=-4.83794324189103 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(21/2448*10)=-3.54314232502653 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: RBM6 [Title/Abstract] AND ARIH2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | RBM6(50099541)-ARIH2(48999045), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | RBM6-ARIH2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RBM6-ARIH2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RBM6-ARIH2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. RBM6-ARIH2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | ARIH2 | GO:0000209 | protein polyubiquitination | 16118314|19340006 |
Tgene | ARIH2 | GO:0006511 | ubiquitin-dependent protein catabolic process | 16118314 |
Tgene | ARIH2 | GO:0016567 | protein ubiquitination | 24076655 |
Tgene | ARIH2 | GO:0048588 | developmental cell growth | 19340006 |
Tgene | ARIH2 | GO:0070534 | protein K63-linked ubiquitination | 19340006 |
Tgene | ARIH2 | GO:0070936 | protein K48-linked ubiquitination | 16118314|19340006 |
Tgene | ARIH2 | GO:0071425 | hematopoietic stem cell proliferation | 16118314|19340006 |
Fusion gene breakpoints across RBM6 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ARIH2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-BH-A1EO-01A | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000442092 | RBM6 | chr3 | 50099541 | - | ENST00000356401 | ARIH2 | chr3 | 48999045 | + | 5697 | 1358 | 338 | 2584 | 748 |
ENST00000442092 | RBM6 | chr3 | 50099541 | - | ENST00000449376 | ARIH2 | chr3 | 48999045 | + | 2935 | 1358 | 338 | 2584 | 748 |
ENST00000266022 | RBM6 | chr3 | 50099541 | - | ENST00000356401 | ARIH2 | chr3 | 48999045 | + | 7184 | 2845 | 259 | 4071 | 1270 |
ENST00000266022 | RBM6 | chr3 | 50099541 | - | ENST00000449376 | ARIH2 | chr3 | 48999045 | + | 4422 | 2845 | 259 | 4071 | 1270 |
ENST00000443081 | RBM6 | chr3 | 50099541 | - | ENST00000356401 | ARIH2 | chr3 | 48999045 | + | 7448 | 3109 | 859 | 4335 | 1158 |
ENST00000443081 | RBM6 | chr3 | 50099541 | - | ENST00000449376 | ARIH2 | chr3 | 48999045 | + | 4686 | 3109 | 859 | 4335 | 1158 |
ENST00000539992 | RBM6 | chr3 | 50099541 | - | ENST00000356401 | ARIH2 | chr3 | 48999045 | + | 5566 | 1227 | 399 | 2453 | 684 |
ENST00000539992 | RBM6 | chr3 | 50099541 | - | ENST00000449376 | ARIH2 | chr3 | 48999045 | + | 2804 | 1227 | 399 | 2453 | 684 |
ENST00000422955 | RBM6 | chr3 | 50099541 | - | ENST00000356401 | ARIH2 | chr3 | 48999045 | + | 5762 | 1423 | 403 | 2649 | 748 |
ENST00000422955 | RBM6 | chr3 | 50099541 | - | ENST00000449376 | ARIH2 | chr3 | 48999045 | + | 3000 | 1423 | 403 | 2649 | 748 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000442092 | ENST00000356401 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.000524823 | 0.9994752 |
ENST00000442092 | ENST00000449376 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.00118358 | 0.9988165 |
ENST00000266022 | ENST00000356401 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.001219448 | 0.99878055 |
ENST00000266022 | ENST00000449376 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.002471804 | 0.99752825 |
ENST00000443081 | ENST00000356401 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.002265637 | 0.9977343 |
ENST00000443081 | ENST00000449376 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.003813345 | 0.9961867 |
ENST00000539992 | ENST00000356401 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.001497998 | 0.998502 |
ENST00000539992 | ENST00000449376 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.003324686 | 0.99667525 |
ENST00000422955 | ENST00000356401 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.000550946 | 0.9994491 |
ENST00000422955 | ENST00000449376 | RBM6 | chr3 | 50099541 | - | ARIH2 | chr3 | 48999045 | + | 0.001263465 | 0.99873656 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >72965_72965_1_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000266022_ARIH2_chr3_48999045_ENST00000356401_length(amino acids)=1270AA_BP=862 MWGDSRPANRTGPFRGSQEERFAPGWNRDYPPPPLKSHAQERHSGNFPGRDSLPFDFQGHSGPPFANVEEHSFSYGARDGPHGDYRGGEG PGHDFRGGDFSSSDFQSRDSSQLDFRGRDIHSGDFRDREGPPMDYRGGDGTSMDYRGREAPHMNYRDRDAHAVDFRGRDAPPSDFRGRGT YDLDFRGRDGSHADFRGRDLSDLDFRAREQSRSDFRNRDVSDLDFRDKDGTQVDFRGRGSGTTDLDFRDRDTPHSDFRGRHRSRTDQDFR GREMGSCMEFKDREMPPVDPNILDYIQPSTQDREHSGMNVNRREESTHDHTIERPAFGIQKGEFEHSETREGETQGVAFEHESPADFQNS QSPVQDQDKSQLSGREEQSSDAGLFKEEGGLDFLGRQDTDYRSMEYRDVDHRLPGSQMFGYGQSKSFPEGKTARDAQRDLQDQDYRTGPS EEKPSRLIRLSGVPEDATKEEILNAFRTPDGMPVKNLQLKEYNTGYDYGYVCVEFSLLEDAIGCMEANQGTLMIQDKEVTLEYVSSLDFW YCKRCKANIGGHRSSCSFCKNPREVTEAKQELITYPQPQKTSIPAPLEKQPNQPLRPADKEPEPRKREEGQESRLGHQKREAERYLPPSR REGPTFRRDRERESWSGETRQDGESKTIMLKRIYRSTPPEVIVEVLEPYVRLTTANVRIIKNRTGPMGHTYGFIDLDSHAEALRVVKILQ NLDPPFSIDGKMVAVNLATGKRRNDSGDHSDHMHYYQGKKYFRDRRGGGRNSDWSSDTNRQGQQSSSDCYIYDSATGYYYDPLAGTYYDP NTQQEVYVPQDPGLPEEEEIKEKKPTSQGKSSSKKEMSKRDGKEKKDRGVTRVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQ PNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPLLPNEELREKYRRY LFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKCNIC IEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKI QERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVERADSYDRGDLENQMHIAEQRR -------------------------------------------------------------- >72965_72965_2_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000266022_ARIH2_chr3_48999045_ENST00000449376_length(amino acids)=1270AA_BP=862 MWGDSRPANRTGPFRGSQEERFAPGWNRDYPPPPLKSHAQERHSGNFPGRDSLPFDFQGHSGPPFANVEEHSFSYGARDGPHGDYRGGEG PGHDFRGGDFSSSDFQSRDSSQLDFRGRDIHSGDFRDREGPPMDYRGGDGTSMDYRGREAPHMNYRDRDAHAVDFRGRDAPPSDFRGRGT YDLDFRGRDGSHADFRGRDLSDLDFRAREQSRSDFRNRDVSDLDFRDKDGTQVDFRGRGSGTTDLDFRDRDTPHSDFRGRHRSRTDQDFR GREMGSCMEFKDREMPPVDPNILDYIQPSTQDREHSGMNVNRREESTHDHTIERPAFGIQKGEFEHSETREGETQGVAFEHESPADFQNS QSPVQDQDKSQLSGREEQSSDAGLFKEEGGLDFLGRQDTDYRSMEYRDVDHRLPGSQMFGYGQSKSFPEGKTARDAQRDLQDQDYRTGPS EEKPSRLIRLSGVPEDATKEEILNAFRTPDGMPVKNLQLKEYNTGYDYGYVCVEFSLLEDAIGCMEANQGTLMIQDKEVTLEYVSSLDFW YCKRCKANIGGHRSSCSFCKNPREVTEAKQELITYPQPQKTSIPAPLEKQPNQPLRPADKEPEPRKREEGQESRLGHQKREAERYLPPSR REGPTFRRDRERESWSGETRQDGESKTIMLKRIYRSTPPEVIVEVLEPYVRLTTANVRIIKNRTGPMGHTYGFIDLDSHAEALRVVKILQ NLDPPFSIDGKMVAVNLATGKRRNDSGDHSDHMHYYQGKKYFRDRRGGGRNSDWSSDTNRQGQQSSSDCYIYDSATGYYYDPLAGTYYDP NTQQEVYVPQDPGLPEEEEIKEKKPTSQGKSSSKKEMSKRDGKEKKDRGVTRVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQ PNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPLLPNEELREKYRRY LFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKCNIC IEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKI QERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVERADSYDRGDLENQMHIAEQRR -------------------------------------------------------------- >72965_72965_3_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000422955_ARIH2_chr3_48999045_ENST00000356401_length(amino acids)=748AA_BP=340 MIQDKEVTLEYVSSLDFWYCKRCKANIGGHRSSCSFCKNPREVTEAKQELITYPQPQKTSIPAPLEKQPNQPLRPADKEPEPRKREEGQE SRLGHQKREAERYLPPSRREGPTFRRDRERESWSGETRQDGESKTIMLKRIYRSTPPEVIVEVLEPYVRLTTANVRIIKNRTGPMGHTYG FIDLDSHAEALRVVKILQNLDPPFSIDGKMVAVNLATGKRRNDSGDHSDHMHYYQGKKYFRDRRGGGRNSDWSSDTNRQGQQSSSDCYIY DSATGYYYDPLAGTYYDPNTQQEVYVPQDPGLPEEEEIKEKKPTSQGKSSSKKEMSKRDGKEKKDRGVTRVSHSVAKLILVNFHWQVSEI LDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPED FVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSE TANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENH NKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVERAD -------------------------------------------------------------- >72965_72965_4_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000422955_ARIH2_chr3_48999045_ENST00000449376_length(amino acids)=748AA_BP=340 MIQDKEVTLEYVSSLDFWYCKRCKANIGGHRSSCSFCKNPREVTEAKQELITYPQPQKTSIPAPLEKQPNQPLRPADKEPEPRKREEGQE SRLGHQKREAERYLPPSRREGPTFRRDRERESWSGETRQDGESKTIMLKRIYRSTPPEVIVEVLEPYVRLTTANVRIIKNRTGPMGHTYG FIDLDSHAEALRVVKILQNLDPPFSIDGKMVAVNLATGKRRNDSGDHSDHMHYYQGKKYFRDRRGGGRNSDWSSDTNRQGQQSSSDCYIY DSATGYYYDPLAGTYYDPNTQQEVYVPQDPGLPEEEEIKEKKPTSQGKSSSKKEMSKRDGKEKKDRGVTRVSHSVAKLILVNFHWQVSEI LDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPED FVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSE TANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENH NKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVERAD -------------------------------------------------------------- >72965_72965_5_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000442092_ARIH2_chr3_48999045_ENST00000356401_length(amino acids)=748AA_BP=340 MIQDKEVTLEYVSSLDFWYCKRCKANIGGHRSSCSFCKNPREVTEAKQELITYPQPQKTSIPAPLEKQPNQPLRPADKEPEPRKREEGQE SRLGHQKREAERYLPPSRREGPTFRRDRERESWSGETRQDGESKTIMLKRIYRSTPPEVIVEVLEPYVRLTTANVRIIKNRTGPMGHTYG FIDLDSHAEALRVVKILQNLDPPFSIDGKMVAVNLATGKRRNDSGDHSDHMHYYQGKKYFRDRRGGGRNSDWSSDTNRQGQQSSSDCYIY DSATGYYYDPLAGTYYDPNTQQEVYVPQDPGLPEEEEIKEKKPTSQGKSSSKKEMSKRDGKEKKDRGVTRVSHSVAKLILVNFHWQVSEI LDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPED FVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSE TANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENH NKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVERAD -------------------------------------------------------------- >72965_72965_6_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000442092_ARIH2_chr3_48999045_ENST00000449376_length(amino acids)=748AA_BP=340 MIQDKEVTLEYVSSLDFWYCKRCKANIGGHRSSCSFCKNPREVTEAKQELITYPQPQKTSIPAPLEKQPNQPLRPADKEPEPRKREEGQE SRLGHQKREAERYLPPSRREGPTFRRDRERESWSGETRQDGESKTIMLKRIYRSTPPEVIVEVLEPYVRLTTANVRIIKNRTGPMGHTYG FIDLDSHAEALRVVKILQNLDPPFSIDGKMVAVNLATGKRRNDSGDHSDHMHYYQGKKYFRDRRGGGRNSDWSSDTNRQGQQSSSDCYIY DSATGYYYDPLAGTYYDPNTQQEVYVPQDPGLPEEEEIKEKKPTSQGKSSSKKEMSKRDGKEKKDRGVTRVSHSVAKLILVNFHWQVSEI LDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPED FVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSE TANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENH NKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVERAD -------------------------------------------------------------- >72965_72965_7_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000443081_ARIH2_chr3_48999045_ENST00000356401_length(amino acids)=1158AA_BP=750 MDFRGRDIHSGDFRDREGPPMDYRGGDGTSMDYRGREAPHMNYRDRDAHAVDFRGRDAPPSDFRGRGTYDLDFRGRDGSHADFRGRDLSD LDFRAREQSRSDFRNRDVSDLDFRDKDGTQVDFRGRGSGTTDLDFRDRDTPHSDFRGRHRSRTDQDFRGREMGSCMEFKDREMPPVDPNI LDYIQPSTQDREHSGMNVNRREESTHDHTIERPAFGIQKGEFEHSETREGETQGVAFEHESPADFQNSQSPVQDQDKSQLSGREEQSSDA GLFKEEGGLDFLGRQDTDYRSMEYRDVDHRLPGSQMFGYGQSKSFPEGKTARDAQRDLQDQDYRTGPSEEKPSRLIRLSGVPEDATKEEI LNAFRTPDGMPVKNLQLKEYNTGYDYGYVCVEFSLLEDAIGCMEANQGTLMIQDKEVTLEYVSSLDFWYCKRCKANIGGHRSSCSFCKNP REVTEAKQELITYPQPQKTSIPAPLEKQPNQPLRPADKEPEPRKREEGQESRLGHQKREAERYLPPSRREGPTFRRDRERESWSGETRQD GESKTIMLKRIYRSTPPEVIVEVLEPYVRLTTANVRIIKNRTGPMGHTYGFIDLDSHAEALRVVKILQNLDPPFSIDGKMVAVNLATGKR RNDSGDHSDHMHYYQGKKYFRDRRGGGRNSDWSSDTNRQGQQSSSDCYIYDSATGYYYDPLAGTYYDPNTQQEVYVPQDPGLPEEEEIKE KKPTSQGKSSSKKEMSKRDGKEKKDRGVTRVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQF VRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPM VIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWM CLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAK -------------------------------------------------------------- >72965_72965_8_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000443081_ARIH2_chr3_48999045_ENST00000449376_length(amino acids)=1158AA_BP=750 MDFRGRDIHSGDFRDREGPPMDYRGGDGTSMDYRGREAPHMNYRDRDAHAVDFRGRDAPPSDFRGRGTYDLDFRGRDGSHADFRGRDLSD LDFRAREQSRSDFRNRDVSDLDFRDKDGTQVDFRGRGSGTTDLDFRDRDTPHSDFRGRHRSRTDQDFRGREMGSCMEFKDREMPPVDPNI LDYIQPSTQDREHSGMNVNRREESTHDHTIERPAFGIQKGEFEHSETREGETQGVAFEHESPADFQNSQSPVQDQDKSQLSGREEQSSDA GLFKEEGGLDFLGRQDTDYRSMEYRDVDHRLPGSQMFGYGQSKSFPEGKTARDAQRDLQDQDYRTGPSEEKPSRLIRLSGVPEDATKEEI LNAFRTPDGMPVKNLQLKEYNTGYDYGYVCVEFSLLEDAIGCMEANQGTLMIQDKEVTLEYVSSLDFWYCKRCKANIGGHRSSCSFCKNP REVTEAKQELITYPQPQKTSIPAPLEKQPNQPLRPADKEPEPRKREEGQESRLGHQKREAERYLPPSRREGPTFRRDRERESWSGETRQD GESKTIMLKRIYRSTPPEVIVEVLEPYVRLTTANVRIIKNRTGPMGHTYGFIDLDSHAEALRVVKILQNLDPPFSIDGKMVAVNLATGKR RNDSGDHSDHMHYYQGKKYFRDRRGGGRNSDWSSDTNRQGQQSSSDCYIYDSATGYYYDPLAGTYYDPNTQQEVYVPQDPGLPEEEEIKE KKPTSQGKSSSKKEMSKRDGKEKKDRGVTRVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQF VRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPM VIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWM CLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAK -------------------------------------------------------------- >72965_72965_9_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000539992_ARIH2_chr3_48999045_ENST00000356401_length(amino acids)=684AA_BP=276 MEKQPNQPLRPADKEPEPRKREEGQESRLGHQKREAERYLPPSRREGPTFRRDRERESWSGETRQDGESKTIMLKRIYRSTPPEVIVEVL EPYVRLTTANVRIIKNRTGPMGHTYGFIDLDSHAEALRVVKILQNLDPPFSIDGKMVAVNLATGKRRNDSGDHSDHMHYYQGKKYFRDRR GGGRNSDWSSDTNRQGQQSSSDCYIYDSATGYYYDPLAGTYYDPNTQQEVYVPQDPGLPEEEEIKEKKPTSQGKSSSKKEMSKRDGKEKK DRGVTRVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHC SVLVKDGVGVGVSCMAQDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFK CRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDI VNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPR -------------------------------------------------------------- >72965_72965_10_RBM6-ARIH2_RBM6_chr3_50099541_ENST00000539992_ARIH2_chr3_48999045_ENST00000449376_length(amino acids)=684AA_BP=276 MEKQPNQPLRPADKEPEPRKREEGQESRLGHQKREAERYLPPSRREGPTFRRDRERESWSGETRQDGESKTIMLKRIYRSTPPEVIVEVL EPYVRLTTANVRIIKNRTGPMGHTYGFIDLDSHAEALRVVKILQNLDPPFSIDGKMVAVNLATGKRRNDSGDHSDHMHYYQGKKYFRDRR GGGRNSDWSSDTNRQGQQSSSDCYIYDSATGYYYDPLAGTYYDPNTQQEVYVPQDPGLPEEEEIKEKKPTSQGKSSSKKEMSKRDGKEKK DRGVTRVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHC SVLVKDGVGVGVSCMAQDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFK CRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDI VNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPR -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:50099541/chr3:48999045) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | ARIH2 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: E3 ubiquitin-protein ligase, which catalyzes ubiquitination of target proteins together with ubiquitin-conjugating enzyme E2 UBE2L3 (PubMed:16118314, PubMed:17646546, PubMed:19340006, PubMed:24076655). Acts as an atypical E3 ubiquitin-protein ligase by working together with cullin-5-RING ubiquitin ligase complex (ECS complex, also named CRL5 complex) and initiating ubiquitination of ECS substrates: associates with ECS complex and specifically mediates addition of the first ubiquitin on ECS targets (By similarity). The initial ubiquitin is then elongated (By similarity). E3 ubiquitin-protein ligase activity is activated upon binding to neddylated form of the ECS complex (PubMed:24076655). Mediates 'Lys-6', 'Lys-48'- and 'Lys-63'-linked polyubiquitination (PubMed:16118314, PubMed:17646546, PubMed:19340006). May play a role in myelopoiesis (PubMed:19340006). {ECO:0000250|UniProtKB:Q9Y4X5, ECO:0000269|PubMed:16118314, ECO:0000269|PubMed:17646546, ECO:0000269|PubMed:19340006, ECO:0000269|PubMed:24076655}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000266022 | - | 15 | 21 | 826_829 | 862.0 | 1124.0 | Compositional bias | Note=Poly-Glu |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000266022 | - | 15 | 21 | 456_536 | 862.0 | 1124.0 | Domain | RRM |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000356401 | 2 | 16 | 135_344 | 85.0 | 494.0 | Region | TRIAD supradomain | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000356401 | 2 | 16 | 359_493 | 85.0 | 494.0 | Region | Ariadne domain | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000449376 | 3 | 17 | 135_344 | 85.0 | 494.0 | Region | TRIAD supradomain | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000449376 | 3 | 17 | 359_493 | 85.0 | 494.0 | Region | Ariadne domain | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000356401 | 2 | 16 | 139_188 | 85.0 | 494.0 | Zinc finger | RING-type 1 | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000356401 | 2 | 16 | 208_270 | 85.0 | 494.0 | Zinc finger | IBR-type | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000356401 | 2 | 16 | 297_326 | 85.0 | 494.0 | Zinc finger | RING-type 2%3B atypical | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000449376 | 3 | 17 | 139_188 | 85.0 | 494.0 | Zinc finger | RING-type 1 | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000449376 | 3 | 17 | 208_270 | 85.0 | 494.0 | Zinc finger | IBR-type | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000449376 | 3 | 17 | 297_326 | 85.0 | 494.0 | Zinc finger | RING-type 2%3B atypical |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000266022 | - | 15 | 21 | 892_895 | 862.0 | 1124.0 | Compositional bias | Note=Poly-Pro |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000266022 | - | 15 | 21 | 915_921 | 862.0 | 1124.0 | Compositional bias | Note=Poly-Glu |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000422955 | - | 13 | 19 | 826_829 | 340.0 | 602.0 | Compositional bias | Note=Poly-Glu |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000422955 | - | 13 | 19 | 892_895 | 340.0 | 602.0 | Compositional bias | Note=Poly-Pro |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000422955 | - | 13 | 19 | 915_921 | 340.0 | 602.0 | Compositional bias | Note=Poly-Glu |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000442092 | - | 11 | 17 | 826_829 | 340.0 | 602.0 | Compositional bias | Note=Poly-Glu |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000442092 | - | 11 | 17 | 892_895 | 340.0 | 602.0 | Compositional bias | Note=Poly-Pro |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000442092 | - | 11 | 17 | 915_921 | 340.0 | 602.0 | Compositional bias | Note=Poly-Glu |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000266022 | - | 15 | 21 | 1051_1097 | 862.0 | 1124.0 | Domain | G-patch |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000422955 | - | 13 | 19 | 1051_1097 | 340.0 | 602.0 | Domain | G-patch |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000422955 | - | 13 | 19 | 456_536 | 340.0 | 602.0 | Domain | RRM |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000442092 | - | 11 | 17 | 1051_1097 | 340.0 | 602.0 | Domain | G-patch |
Hgene | RBM6 | chr3:50099541 | chr3:48999045 | ENST00000442092 | - | 11 | 17 | 456_536 | 340.0 | 602.0 | Domain | RRM |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000356401 | 2 | 16 | 65_112 | 85.0 | 494.0 | Region | UBA-like | |
Tgene | ARIH2 | chr3:50099541 | chr3:48999045 | ENST00000449376 | 3 | 17 | 65_112 | 85.0 | 494.0 | Region | UBA-like |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
RBM6 | |
ARIH2 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to RBM6-ARIH2 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to RBM6-ARIH2 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |